252 related articles for article (PubMed ID: 25338281)
21. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.
Axelsson R; Bach-Gansmo T; Castell-Conesa J; McParland BJ;
Acta Radiol; 2010 Feb; 51(1):40-6. PubMed ID: 20001475
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
23. Utility of Tc-PEG4-E[PEG4-c(RGDfK)]2 in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic Antigen Levels.
Gao R; Zhang G; Chen L; Zhu Z; Wang F; Yang A
Med Princ Pract; 2015; 24(3):244-9. PubMed ID: 25871432
[TBL] [Abstract][Full Text] [Related]
24. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
[TBL] [Abstract][Full Text] [Related]
25. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
26. (99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.
Zhang Z; Zhao X; Ding C; Wang J; Zhang J; Wang F
Cancer Biother Radiopharm; 2016 Sep; 31(7):238-45. PubMed ID: 27563805
[TBL] [Abstract][Full Text] [Related]
27. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
Sahin E; Zincirkeser S; Akcan AB; Elboga U
J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
[TBL] [Abstract][Full Text] [Related]
28. Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT imaging in a case of pituitary metastases.
Hou Y; Zhu Z; Jin X; Wang R; Xing B
Clin Nucl Med; 2013 Jul; 38(7):550-2. PubMed ID: 23657139
[TBL] [Abstract][Full Text] [Related]
29. Cerebral infarction on 99mTc-MDP SPECT/CT imaging.
Guo J; Hu S; Wang H; Kuang A
Clin Nucl Med; 2013 Nov; 38(11):925-7. PubMed ID: 24089066
[TBL] [Abstract][Full Text] [Related]
30. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.
Yang S; Dong Q; Yao M; Shi M; Ye J; Zhao L; Su J; Gu W; Xie W; Wang K; Du Y; Li Y; Huang Y
Nucl Med Biol; 2009 Apr; 36(3):313-21. PubMed ID: 19324277
[TBL] [Abstract][Full Text] [Related]
31. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.
Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C
Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172
[TBL] [Abstract][Full Text] [Related]
32. 99mTc-3PRGD2 single-photon emission computed tomography/computed tomography for the diagnosis of choroidal melanoma: A preliminary STROBE-compliant observational study.
Yan B; Fu T; Liu Y; Wei W; Dai H; Fang W; Wang F
Medicine (Baltimore); 2018 Oct; 97(40):e12441. PubMed ID: 30290601
[TBL] [Abstract][Full Text] [Related]
33. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
34. Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal System.
Kabunda J; Gabela L; Kalinda C; Aldous C; Pillay V; Nyakale N
Clin Nucl Med; 2021 Jul; 46(7):562-568. PubMed ID: 34028421
[TBL] [Abstract][Full Text] [Related]
35. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma.
Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N
Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of a congenital urine bladder diverticulum by 99mTc-MDP SPET/CT scan in a female with bone metastases.
Meng Z; Tan J; Dong F; Jia Q; Zhang F
Hell J Nucl Med; 2009; 12(3):276-8. PubMed ID: 19936344
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of
Wu Y; Wang Y; Yang Z; Teng C; Guo Z
Thorac Cancer; 2022 Nov; 13(21):3025-3031. PubMed ID: 36104010
[TBL] [Abstract][Full Text] [Related]
40. ⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.
Ji B; Chen B; Wang T; Song Y; Chen M; Ji T; Wang X; Gao S; Ma Q
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1362-70. PubMed ID: 25947573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
